• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anthropometric measurements and survival after a prostate cancer diagnosis.前列腺癌诊断后的人体测量学指标与生存。
Br J Cancer. 2018 Feb 20;118(4):607-610. doi: 10.1038/bjc.2017.440. Epub 2017 Dec 12.
2
Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.在 EPIC 研究中,临近诊断时的肥胖评估与前列腺癌预后。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae070.
3
Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.腰围、腰臀比、体重指数与前列腺癌风险:北美病例对照研究“前列腺癌与环境研究”的结果
Urol Oncol. 2015 Nov;33(11):494.e1-7. doi: 10.1016/j.urolonc.2015.07.006. Epub 2015 Aug 14.
4
Post-diagnosis alcohol intake and prostate cancer survival: A population-based cohort study.诊断后饮酒与前列腺癌生存:基于人群的队列研究。
Int J Cancer. 2018 Jul 15;143(2):253-262. doi: 10.1002/ijc.31307. Epub 2018 Feb 23.
5
No Association of Waist Circumference and Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort.腰围与前列腺癌之间无关联:癌症预防研究 II 营养队列研究。
Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1812-1814. doi: 10.1158/1055-9965.EPI-17-0802.
6
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.一生中多次人体测量与前列腺癌诊断、转移及死亡情况
Eur Urol. 2015 Dec;68(6):1076-82. doi: 10.1016/j.eururo.2015.03.017. Epub 2015 Mar 18.
7
New indexes of body fat distribution and sex-specific risk of total and cause-specific mortality: a prospective cohort study.新型体脂分布指标与全因及死因特异性死亡率的性别特异性风险:一项前瞻性队列研究。
BMC Public Health. 2018 Apr 2;18(1):427. doi: 10.1186/s12889-018-5350-8.
8
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.肥胖与中年男性前列腺癌转移风险增加以及初次癌症诊断后的死亡风险增加有关。
Cancer. 2007 Mar 15;109(6):1192-202. doi: 10.1002/cncr.22534.
9
The impact of obesity on overall and cancer specific survival in men with prostate cancer.肥胖对男性前列腺癌患者总体和癌症特异性生存的影响。
J Urol. 2009 Jul;182(1):112-7; discussion 117. doi: 10.1016/j.juro.2009.02.118. Epub 2009 May 17.
10
Body mass index and weight change in men with prostate cancer: progression and mortality.前列腺癌男性的体重指数与体重变化:疾病进展及死亡率
Cancer Causes Control. 2014 Aug;25(8):933-43. doi: 10.1007/s10552-014-0393-3. Epub 2014 May 9.

引用本文的文献

1
Adiposity Status Close to Diagnosis and Its Association with Prostate Cancer Survival in the UK Biobank.英国生物银行中接近诊断时的肥胖状况及其与前列腺癌生存的关联。
Cancer Res Commun. 2025 Jul 1;5(7):1155-1170. doi: 10.1158/2767-9764.CRC-25-0124.
2
Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio.探讨临床上显著的前列腺癌、肥胖与血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值之间的相关性。
BMC Urol. 2024 Oct 16;24(1):226. doi: 10.1186/s12894-024-01617-2.
3
Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study.在 EPIC 研究中,临近诊断时的肥胖评估与前列腺癌预后。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae070.
4
Association between adiposity after diagnosis of prostate cancer and mortality: systematic review and meta-analysis.前列腺癌诊断后肥胖与死亡率之间的关联:系统评价与荟萃分析
BMJ Med. 2023 Jun 25;2(1):e000339. doi: 10.1136/bmjmed-2022-000339. eCollection 2023.
5
Obesity Paradox: Fact or Fiction?肥胖悖论:事实还是虚构?
Curr Obes Rep. 2023 Jun;12(2):75-85. doi: 10.1007/s13679-023-00497-1. Epub 2023 Feb 20.
6
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.接受前列腺放射治疗的男性的身体成分与死亡率:NRG/RTOG 9406 和 NRG/RTOG 0126 的汇总分析。
Cancer. 2023 Mar 1;129(5):685-696. doi: 10.1002/cncr.34596. Epub 2022 Dec 29.
7
Adiposity and cancer survival: a systematic review and meta-analysis.肥胖与癌症生存:系统评价和荟萃分析。
Cancer Causes Control. 2022 Oct;33(10):1219-1246. doi: 10.1007/s10552-022-01613-7. Epub 2022 Aug 15.
8
Obesity as a Risk Factor for Prostate Cancer Mortality: A Systematic Review and Dose-Response Meta-Analysis of 280,199 Patients.肥胖作为前列腺癌死亡的一个风险因素:对280,199例患者的系统评价和剂量反应荟萃分析
Cancers (Basel). 2021 Aug 19;13(16):4169. doi: 10.3390/cancers13164169.
9
Associations of fat and muscle mass with overall survival in men with prostate cancer: a systematic review with meta-analysis.脂肪和肌肉质量与前列腺癌男性患者总生存的相关性:系统评价与荟萃分析。
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):615-626. doi: 10.1038/s41391-021-00442-0. Epub 2021 Aug 21.
10
Diagnosis of Waist Muscle Injury after Exercise Based on High-Frequency Ultrasound Image.基于高频超声图像的运动后腰部肌肉损伤的诊断。
J Healthc Eng. 2021 Mar 26;2021:5528309. doi: 10.1155/2021/5528309. eCollection 2021.

本文引用的文献

1
Next Steps in Understanding the Obesity Paradox in Cancer.理解癌症中的肥胖悖论的后续步骤。
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):12. doi: 10.1158/1055-9965.EPI-16-0764.
2
Obesity and Prostate Cancer.肥胖与前列腺癌
Recent Results Cancer Res. 2016;208:137-153. doi: 10.1007/978-3-319-42542-9_8.
3
Obesity and Other Cancers.肥胖与其他癌症。
J Clin Oncol. 2016 Dec 10;34(35):4231-4237. doi: 10.1200/JCO.2016.68.4837. Epub 2016 Nov 7.
4
Physical Activity and Survival After Prostate Cancer.体力活动与前列腺癌患者的生存
Eur Urol. 2016 Oct;70(4):576-585. doi: 10.1016/j.eururo.2015.12.032. Epub 2016 Jan 7.
5
Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.前列腺癌患者的体重指数与死亡率:一项剂量反应荟萃分析。
Prostate Cancer Prostatic Dis. 2016 Jun;19(2):122-31. doi: 10.1038/pcan.2015.64. Epub 2016 Jan 12.
6
Impact of Smoking and Excess Body Weight on Overall and Site-Specific Cancer Mortality Risk.吸烟和超重对总体及特定部位癌症死亡风险的影响。
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1516-22. doi: 10.1158/1055-9965.EPI-15-0415. Epub 2015 Jul 27.
7
Current and predicted prevalence of obesity in Canada: a trend analysis.加拿大肥胖症的当前及预测患病率:一项趋势分析。
CMAJ Open. 2014 Mar 3;2(1):E18-26. doi: 10.9778/cmajo.20130016. eCollection 2014 Jan.
8
Sarcopenia in older adults.老年人肌肉减少症。
Curr Opin Rheumatol. 2012 Nov;24(6):623-7. doi: 10.1097/BOR.0b013e328358d59b.
9
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis.体重指数、前列腺癌特异性死亡率和生化复发:系统评价和荟萃分析。
Cancer Prev Res (Phila). 2011 Apr;4(4):486-501. doi: 10.1158/1940-6207.CAPR-10-0229. Epub 2011 Jan 13.
10
Case-control study of lifetime total physical activity and prostate cancer risk.终生总体身体活动与前列腺癌风险的病例对照研究。
Am J Epidemiol. 2004 Apr 15;159(8):740-9. doi: 10.1093/aje/kwh106.

前列腺癌诊断后的人体测量学指标与生存。

Anthropometric measurements and survival after a prostate cancer diagnosis.

机构信息

Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Holy Cross Centre, Calgary, AB, Canada.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, AB, Canada.

出版信息

Br J Cancer. 2018 Feb 20;118(4):607-610. doi: 10.1038/bjc.2017.440. Epub 2017 Dec 12.

DOI:10.1038/bjc.2017.440
PMID:29235565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5830594/
Abstract

BACKGROUND

Evidence regarding the role of anthropometrics in prostate cancer survival is inconsistent. We examined the associations between anthropometric measures and survival outcomes.

METHODS

Men diagnosed with prostate cancer (n=987) were recruited into a population-based case-control study between 1997 and 2000 then a prospective cohort study between 2000 and 2002 where anthropometric measurements (weight, height, body mass index, waist circumference, waist-hip ratio) were taken and participants were followed up to 19 years for survival outcomes. Cox proportional hazards were used to examine these associations.

RESULTS

Survival analyses suggested no clear pattern of associations between post-diagnosis anthropometric measurements and all-cause mortality, prostate-specific mortality, first recurrence/progression or new primary cancer.

CONCLUSIONS

We did not find a significant trend relating anthropometrics to survival outcomes after prostate cancer diagnosis. Continued assessment of objective measurements of body composition over the life-course is warranted to determine true associations between anthropometrics and survival after prostate cancer.

摘要

背景

关于人体测量学在前列腺癌生存中的作用的证据不一致。我们研究了人体测量指标与生存结果之间的关系。

方法

1997 年至 2000 年间,我们招募了 987 名被诊断患有前列腺癌的男性参加一项基于人群的病例对照研究,然后在 2000 年至 2002 年期间参加一项前瞻性队列研究,在此期间测量了人体测量指标(体重、身高、体重指数、腰围、腰臀比),并对参与者进行了长达 19 年的生存结果随访。使用 Cox 比例风险模型来检查这些关联。

结果

生存分析表明,在诊断后,人体测量指标与全因死亡率、前列腺特异性死亡率、首次复发/进展或新发原发性癌症之间没有明显的关联模式。

结论

我们没有发现与人体测量学与前列腺癌诊断后生存结果相关的显著趋势。在整个生命周期中,需要继续评估身体成分的客观测量,以确定人体测量学与前列腺癌后生存之间的真实关联。